首页 >
法规速递
-
国家药监局关于发布仿制药参比制剂目录（第九十五批）的通告（2025年第33号）-2025/9/2
2025-09-03查看详情 > -
Page: CHMP: Working parties and other groups-2025/10/6
2025-10-08查看详情 > -
Document: Concept paper on a paediatric update on the guideline on the development of new medicinal products for the treatment of Ulcerative Colitis-2025/11/13
2025-11-14查看详情 > -
Document: List of medicinal products under additional monitoring-2025/12/10
2025-12-11查看详情 > -
关于将依维莫司微片纳入《儿童抗肿瘤药物研发鼓励试点计划（星光计划）》试点项目的公示-2026/1/22
2026-01-23查看详情 > -
Document: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) annual activity report 2025-2026/2/26
2026-02-27查看详情 > -
Page: Type-IB variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Document: Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 20-23 April 2026-2026/5/8
2026-05-09查看详情 > -
关于公开征求《干眼治疗药物临床试验技术指导原则（征求意见稿）》意见的通知-2022/11/18
2022-11-25查看详情 > -
国家药监局药审中心关于发布《人源干细胞产品药学研究与评价技术指导原则（试行）》的通告（2023年第33号）-2023/4/27
2023-04-28查看详情 >
